Biotricity to present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th

REDWOOD CITY, Calif., May 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Shareholder Updates

Biotricity issues shareholder update

REDWOOD CITY, Calif., May 05, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotres

Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022

REDWOOD CITY, Calif., Mar 22, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotricity named Fast Company

Biotricity named to Fast Company’s annual list of the World’s 50 Most Innovative Companies for 2022

REDWOOD CITY, Calif., Mar 08, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotricity, Inc. to attend 34th annual Roth Conference March 13th-15th

REDWOOD CITY, Calif., Mar 04, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotres - FDA cleared

Biotricity now taking pre-orders for its Biotres wireless wearable cardiac monitoring device

REDWOOD CITY, Calif., Feb 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Investor call

Biotricity releases Fiscal 2022 third quarter financial results

REDWOOD CITY, Calif., Feb 14, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Third Quarter Update

Biotricity to report third quarter fiscal 2022 financial results on February 14, 2022

REDWOOD CITY, Calif., Feb 08, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotres

Biotricity receives FDA 510(k) clearance for its Biotres Cardiac Monitoring Device

REDWOOD CITY, Calif., Jan 24, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Bioheart device with ticker

Biotricity expands distribution of new Bioheart device on Amazon.com

REDWOOD CITY, Calif., Dec 28, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions,…

Updates

Biotricity completes $12 million non-dilutive debt financing

REDWOOD CITY, Calif., Dec 27, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions,…

Company growth

Biotricity, a leader in remote cardiac health monitoring solutions, issues company roadmap in 2021 shareholder letter

REDWOOD CITY, Calif., Dec 07, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company,…